Media OutReach
PUYI OPTICAL and ZEISS Officially Become Global Strategic Partners

Offering an Elevated Professional Vision Care Experience at the PUYI VISION CARE LAB in Central
HONG KONG SAR – Media OutReach Newswire – 14 February 2025 – PUYI OPTICAL is delighted to announce its partnership with ZEISS as a “Global Strategic Partner.” The collaboration will enhance the offerings at the PUYI VISION CARE LAB in the Central flagship store by integrating the optical expertise from professional optometrists and a full suite of ZEISS optical instruments and cutting-edge technology, delivering personalized vision care solutions. From prescription to optical lens customization, customers will experience the exceptional and attentive service offered by PUYI OPTICAL and ZEISS.
ZEISS strengthens commitment to the Asia-Pacific region
PUYI OPTICAL and ZEISS have been collaborating seamlessly in the optical field, transcending traditional business boundaries and redefining new integration on innovative technology and exceptional service. In 2013, the first “PUYI ZEISS Optical Lab” was launched at Puyi’s flagship store in Central, equipped with a comprehensive suite of state-of-the-art ZEISS optical instruments and extensive vision care solutions. This successful model has since been expanded to all PUYI OPTICAL stores in Hong Kong, Macau, Mainland China, Taiwan, and Singapore, effectively addressing diverse vision care needs. The successful launch of the ZEISS SmartLife PRO lens in 2020 also resulted in significant sales growth across PUYI OPTICAL stores.
The designation of “Global Strategic Partner” signifies that PUYI OPTICAL and ZEISS will integrate their long-standing commitment to customer-centricity into a pivotal component of product research and development. In alignment with the growing trend towards consumer focus, the collaboration between Puyi and ZEISS would develop the most suitable optical products. Therefore, ZEISS’s business development efforts will concentrate on the Asia-Pacific region, bringing together its top research teams to establish a global innovation hub. This initiative will not only significantly enhance research and development cycles to meet the demands of a vast and promising global market but also reinforce the increasing importance of the Asian market to ZEISS.
Mr. Jeffery Yau, the founder and CEO of PUYI OPTICAL, expressed his enthusiasm about the partnership with ZEISS. They are thrilled that PUYI OPTICAL has officially become a ‘Global Strategic Partner’ with ZEISS. They are committed to providing innovative and exceptional retail services, leveraging ZEISS’s advanced technology and expertise to enhance customers’ vision care experiences. As a pioneer in their respective fields, the partnership between PUYI OPTICAL and ZEISS would drive continuous product innovation to meet the evolving needs of their customers. Together, they will elevate the overall experience in vision care, delivering superior services and products.
Mr. SVEN HERMANN, member of the Executive Board of Carl Zeiss AG, Head of ZEISS Consumer Markets Segment, stated PUYI OPTICAL, as ZEISS’s core partner in China and Singapore, has set a new standard in the global optical retail sector with its exceptional service experience. He expressed his honor in elevating this collaboration to “Global Strategic Partner” and highlighted the exclusive launch of personalized optical solutions, such as the ZEISS SmartLife PRO Individual 3.0 and ZEISS i.Scription, which offered customers an unparalleled optical experience. Furthermore, Sven revealed that ZEISS LuminArt, set to launch in 2025, marks a groundbreaking advancement that will significantly enhance the overall experience in vision care.
PUYI VISION CARE LAB offers premium professional vision care services
The newly established PUYI VISION CARE LAB is located in THE MARQUE, the flagship store of PUYI OPTICAL in the heart of Central. The lab combines the expertise of PUYI OPTICAL’s professional optometrists with an extensive suite of ZEISS optical instruments and cutting-edge technology. This setup provides customers with comprehensive eye health and vision assessments. The exclusively introduced precision refractive instrument, i.Profiler® Plus, accurately captures visual performance from eyes, consolidating it into comprehensive prescription information. This is complemented by the ZEISS VisuFit 1000 digital centration device, which captures data on frame and facial features. Through meticulous facial measurements and frame fitting analyses, customized lenses are tailored to fit the frames perfectly, ensuring a personalized and comfortable visual experience for customers. Furthermore, the facility is equipped with medical-grade ZEISS instruments and technology, enabling comprehensive personal vision analysis, precise eye measurements, and performance assessments. This allows customers to gain a deeper and more thorough understanding of their eye health.
Exclusive ZEISS’s lens customization solutions
As the demand for personalized lenses continues to increase, customers now expect lenses tailored to their specific vision needs and lifestyles. This trend has driven PUYI OPTICAL and ZEISS to enhance their efforts in providing precise personalized prescription services and high-quality lifelong vision care solutions. To address the need for customized lenses, PUYI OPTICAL has exclusively launched the ZEISS SmartLife PRO Individual 3.0. This product features intelligent design to meet the diverse visual needs of modern individuals. By utilizing advanced screening instruments and professional optometric services, the system collects individual data from customer’s eyes, accurately capturing their unique visual needs and behaviors to create lenses that perfectly align with their vision requirements.
Additionally, PUYI OPTICAL has exclusively introduced ZEISS i.Scription® lens technology. This advanced visual measurement technology not only enhances the accuracy of the lenses but also provides a personalized vision care solution for each customer. By capturing a greater volume of visual data, ZEISS i.Scription® allows for precise assessments of individual vision needs and the customization of lenses based on their prescriptions and facial contours. Utilizing sophisticated instruments, this technology conducts comprehensive measurements of the eyes, ensuring that the lenses deliver clearer and sharper visual results both during the day and under artificial lighting at night.
Two Brands, One Vision
Over the past decade, PUYI OPTICAL and ZEISS have evolved from an initial collaboration into a global partnership, driven by their shared belief in “Two Brands, One Vision.” This common vision has enabled PUYI OPTICAL and ZEISS to seamlessly combine retail expertise with cutting-edge technology. Looking ahead, they will continue to develop the most suitable optical products for the market and explore new frontiers in the eyewear industry together.Hashtag: #PuyiOptical #ZEISS
The issuer is solely responsible for the content of this announcement.
About Puyi Group
Established in 2001, Puyi Group was founded with the ambition to create the most prestigious and sophisticated experiences in eyewear. In the past decades, The Group has successfully transformed the role of eyewear from an ordinary necessity to a sophisticated accessory and has paved its way as a global leader and pioneer in luxury eyewear. With customers as its foremost priority, the Group strives to offer prestigious, personalised and one-stop eyewear experiences. Puyi Group selectively collaborates with globally-renowned eyewear and fashion brands to bring forth an unparalleled assortment of high-quality eyewear products. The Group offers professional services, introduces cutting-edge eye exam equipment and engages the corporate social responsibility to bring vision care and eyewear experiences to new heights.
Puyi Group boasts a substantial retail presence across Mainland China, Hong Kong and Macao Special Administrative Regions, Taiwan Regions, and Singapore.
Puyi Group has created a variety of luxury retail concepts: Puyi Optical (Luxury & Prestige) * Glasstique (Contemporary) * Point De Vue (Male Concept Store) * Reflections (Female Concept Store) * O-O Shop (Modern Concept) * 2020EYEhaus (Lifestyle). The Group also runs standalone boutiques for international brands, such as GENTLE MONSTER, LINDA FARROW, LINDBERG by PUYI OPTICAL and LOTOS.
Puyi Group is a member of Europe Group, and a sister company of Europe Watch Company.
Website: https://www.puyi.com
Facebook: https://www.facebook.com/PuyiOptical
Instagram: https://www.instagram.com/PuyiOptical
About ZEISS
As a top optical brand with a history spanning 178 years, ZEISS is one of the impactful optical product brands in the world. For over a century, ZEISS has led the market by delivering exceptionally high-quality optical products and professional expertise. As a forward-thinking classic optical brand, ZEISS has never ceased its pursuit of ultimate precision and innovative technology in the manufacturing of optical lenses. The brand aims to be a lifelong partner in vision care for everyone, dedicated to ensuring that individuals can see as clearly and as far as possible. This commitment stems from our deep belief that each person’s vision is uniquely different.
Media OutReach
Asia’s digital future takes centre stage at Economist Impact’s 5th annual Technology for Change Asia in Hong Kong

Taking place in Hong Kong for the 2nd year, the two-day event explored key themes including the future of work in the AI era, the quantum revolution, sustainable tech solutions, human-centered innovation, the Greater Bay Area’s transformation, China’s digital roadmap, smart and green mobility, and ethical AI.
In an opening ministerial keynote address, the Honourable Paul Chan Mo-po, GBM, GBS, MH, JP, Financial Secretary of the Government of the Hong Kong Special Administrative Region, said that Hong Kong, along with the Greater Bay Area, is poised to emerge as a leading international innovation centre because the region is building an ecosystem of patient capital, fostering a pro-innovation environment, and leveraging its unique strengths under the ‘one country, two systems’ arrangement to attract top-tier talent and drive technological progress, including in cutting-edge fields like AI.
Over 70 speakers, including renowned physicist Professor Brian Cox, shared insights on the region’s emerging investment and business opportunities. The event highlighted the unique position of the Greater Bay Area in using technology for business impact, and featured discussions on how businesses and governments can prioritise the human element in technology research and adoption to close the digital divide.
The event featured speakers from leading organisations including Alibaba.com, Booking.com, Deutsche Bank, DHL, Google, HSBC, IBM, JLL, Klook, Lan Kwai Fong Group, Li & Fung, Li Auto, LinkedIn, Mercedes-Benz Group, OCBC, Swire Hotels Group, Tencent Quantum Lab, Uber, and WhatsApp, and many more.
“From quantum computing to ethical AI, Technology for Change Asia tackled the innovations defining our future,” said Charles Ross, principal, technology and society, Asia-Pacific at Economist Impact. “The conversations we had were not just about technology but about shaping a more resilient and equitable world.”
The 5th annual Technology for Change Asia was sponsored by the Kellogg-HKUST Executive MBA Program, Hong Kong Science & Technology Parks Corporation, Tata Communications, IBM, AIA and McKinsey Global Institute. The event was supported by Brand Hong Kong, The Hong Kong Tourism Board, AI Club Asia, Asia MarTech Society, and the British Consulate-General Hong Kong. The official travel partner was Cathay Pacific.
For more information about Technology for Change Asia, please visit http://econimpact.co/TFCpress
Hashtag: #EconomistImpact
The issuer is solely responsible for the content of this announcement.
About Economist Impact
Economist Impact empowers businesses, governments and foundations to catalyse change and enable progress. Uniting the expertise The Economist Group is known for under a single brand, Economist Impact brings together policy research and insights, data visualisation, custom storytelling, events and media. Economist Impact combines the rigour of a think tank with the creativity of a media brand, engaging an influential audience in the areas of sustainability, healthcare and new globalisation. Visit www.economistimpact.com for more information.
Media OutReach
VinFuture Prize empowered the woman scientist Dr. Firdausi Qadri to give back to Bangladesh

Sharing with the VinFuture Foundation, Dr. Qadri reflects on her groundbreaking work and her passion for expanding STEM education for women. In the face of societal barriers, particularly in Bangladesh, she remains committed to empowering women in science and using her VinFuture Prize value to strengthen the country’s scientific community.
The ongoing battle against cholera
Having established herself as one of the scientific titans in the vaccine area, Dr. Qadri has developed a single oral dose of an affordable cholera vaccine to address the public health needs in Bangladesh. Her research opens the possibility of large-scale vaccination campaigns in poor countries to prevent outbreaks and reduce the healthcare cost burden, allowing them to invest in education and economic activities. This revolutionizing discovery has earned her global recognition, including the 2024 VinFuture Special Prize for Innovators from Developing Countries.
“The VinFuture Prize was completely unexpected, but it has given me immense energy and a profound sense of purpose to turn scientific solutions into real-world applications that benefit those in adverse settings, including humanitarian crises globally,” Dr. Qadri said.
Beyond its personal significance, the VinFuture Prize also empowered Dr. Qadri to give back to her home country. In 2014, Dr. Qadri formed a non-profit research institution called the ideSHi (Institute for Developing Science and Health Initiatives) located on the 11th floor of Blue Moon Gram Tower in ECB Chattar, Dhaka. She shared an astounding initiative to expand this institute using the 500,000 USD prize value from VinFuture, “Together with the VinFuture Prize money and a quarter of my personal funds, I took a bold step forward, acquiring an additional 5,000 square feet of space within the same building as ideSHi’s original facility,” she elaborated.
This facility is a bold initiative dedicated to improving public health and nurturing the next generation of scientists. Since then, this institute provides state-of-the-art facilities, offers training programs, collaborates with international partners, conducts research on genetic diseases including thalassemia – the most common blood disorder in Bangladesh – as well as infectious diseases.
“Over the past decade, ideSHi has expanded tremendously, and this new extension will allow us to tackle even more critical health challenges while further strengthening scientific capacity in Bangladesh,” she shared. “With prize money received from VinFuture, I am confident that this support will help ideSHi develop pragmatic solutions to public health challenges and ultimately help advance Bangladesh’s position in biomedical research.”
The achievement results in her determination after witnessing firsthand the dire impact of cholera and diarrheal diseases. Her journey began as a scientist with a deep passion for immunology, later on extended her work beyond the laboratory to the field, fully devoted to the cause of uplifting the lives of Bangladesh and beyond.
However, through her extensive work in diarrheal diseases at their main hospital in Bangladesh, Dr. Qadri estimates an annual intake of approximately 200,000 patients, with 90-95% comes from impoverished backgrounds. Living in overcrowded conditions with shared toilets, kitchens, and bathrooms, they face rapid disease transmission. “If one person contracts cholera, the infection can spread to three other people in the family and beyond due to contaminated hands and food,” Dr. Qadri explained. “It’s very difficult to control.”
Recognizing the persistent devastation of global health crises, Dr. Qadri extended her research beyond the laboratory. She conducted field studies on vaccine effectiveness, distribution strategies, and public health interventions. Her efforts extended beyond academia as she worked more with the government, advocating for necessary actions to improve healthcare access.
“Over 15 to 20 years, my work has evolved to encompass not just vaccine development, but also implementation strategies – exploring the effectiveness of different modes in delivering vaccines and understanding how to integrate water, sanitation, and hygiene (WASH) with vaccination programs to achieve cholera control,” she noted.
Dr. Qadri emphasized that cholera remains a disease of poverty, often overlooked due to its association with inadequate sanitation and clean water access. She also pointed out that some governments were reluctant to acknowledge the disease’s prevalence, fearing for their global image. Therefore, she expressed deep gratitude and immense joy at being recognized by such a prestigious global award as the VinFuture Prize. “This recognition is a tremendous honor and serves as a motivation for me to move ahead,” she shared.
Breaking glass ceilings
Dr. Qadri’s dedication to rigorous scientific research and her success in the cholera vaccine area serves as an inspiration for young women all over the world. However, for women in science, particularly in developing countries across Asia, the road is often fraught with challenges. Deep-seated prejudices and invisible glass ceilings make it difficult for women to gain recognition in male-dominated fields.
“I always want to be known as a scientist, not a “woman scientist,” who works alongside men as equals“, Dr. Qadri shared. “But I cannot deny that acceptance has not always come easily.”
The unwavering support of her family played a crucial role, encouraging her to push boundaries and proving that a woman is just as capable as a man. “I traveled to remote areas, worked long hours in the field, and committed myself fully to scientific research. I have managed to overcome many prejudices, though challenges remain,” she noted.
It is also a driving force that motivates her to passionately advocate for empowering women in STEM education. According to her, science, technology, engineering, and mathematics are the foundation of progress, driving innovation and shaping the future. Yet, women remain underrepresented in STEM fields, not only in developing countries but even in advanced economies.
“If we truly want to make a meaningful contribution to the world, women must be part of this transformation,” Dr. Qadri emphasized.
Many hesitate to pursue careers in STEM, not due to a lack of ability but because of societal expectations and deeply ingrained biases. Fields including engineering and mathematics, in particular, remain male-dominated, with cultural norms dictating which professions are deemed “suitable” for women.
Another critical factor is the cost and commitment required. STEM education is more demanding, expensive, and time-intensive compared to fields including finance or commerce. Success in STEM requires years of dedication and persistence, making it an uphill battle, especially for women who must balance professional ambitions with societal expectations of family life.
“I try to use my journey to show young women that it is possible to have a family, raise children, and do science.” She remarked, “You just need to know the mechanism to do it. There is no secret formula: just focus, perseverance, and unwavering commitment to the work you choose to do.”
Addressing health disparities
Driven by the goal to seek effective preventive public health solutions for Bangladesh and other developing countries, Dr. Qadri focuses on large-scale clinical studies using Vietnamese live vaccine train, which allowed her to conclude the benefit, power and feasibility of an oral dose of an affordable vaccine.
“Vietnam, which has been able to control cholera better through concerted public health efforts, has always been an example I reflected on.” She stated, “If Vietnam can better control cholera through a comprehensive public health approach, why can’t we?”
Besides vaccination, the scientific titan emphasized the need for a holistic approach, including improvements in WASH education, and surveillance. However, behavioral change and access to clean water remain significant hurdles. Thus, according to Dr. Qadri, to provide crucial protection in the short term, there are two key strategies: reactive vaccination during an outbreak and preventive vaccination to build immunity.
However, a major obstacle the world faces is the global shortage of cholera vaccines. “Despite cholera affecting millions across Asia, Africa, and Latin America, only 80 million vaccine doses are currently available annually. This is far below what is needed – Bangladesh alone requires 100 million doses in the coming years,” she noted.
The economic constraints surrounding cholera vaccines also present a challenge. Since cholera is often considered a “disease of poverty,” many pharmaceutical companies hesitate to invest in its production due to low profit margins. “This is already happening,” she stressed.
To address this, Dr. Qadri actively advocates for increased vaccine production in Bangladesh. She shared that one of her team’s key achievements has been demonstrating that in a major outbreak, giving the vaccine in a reactive way can quickly reduce the number of cases. “We have implemented this strategy in multiple regions of Bangladesh,” Dr. Qadri added.
“More importantly, as a result of our dedication, we now have a national cholera control plan, centered on preventive vaccination, ensuring that people receive doses regularly – whether annually or every three years – to stay protected before outbreaks occur. This is a significant milestone in our fight against the disease.” she said.
Hashtag: #VinFuture
https://vinfutureprize.org/vinfuture-prize-nomination/
The issuer is solely responsible for the content of this announcement.
VinFuture
The VinFuture Foundation, established on International Human Solidarity Day on December 20th, 2020, is a non-profit organization co-founded by billionaire Mr. Pham Nhat Vuong and his wife, Mrs. Pham Thu Huong. The Foundation’s core activity is awarding the annual VinFuture Prize, which recognizes transformative scientific and technological innovations capable of making significant positive changes in the lives of millions of people worldwide.
The nomination period for the 2025 VinFuture Prize will close at 2:00 PM on April 17, 2025 (Vietnam time, GMT+7).
The VinFuture Prize consists of four prestigious awards presented each year. The most esteemed is the VinFuture Grand Prize, valued at US$3 million, making it one of the largest annual prizes globally. Additionally, there are three Special Prizes, each valued at US$500,000, specifically dedicated to honoring women innovators, innovators from developing countries, and innovators with outstanding achievements in emerging fields.
Media OutReach
HOFA Gallery and PhillipsX Presents SPACES II: Capturing the Ephemera at Phillips’ Asia Headquarters in Hong Kong’s West Kowloon Cultural District

Exploring art, technology and impermanence at Phillips during Hong Kong Art Week 2025, featuring seven visionary artists: Refik Anadol, Sougwen Chung, Random International, Tyler Hobbs, Addie Wagenknecht, Gina Choy & Maja Petrić
HONG KONG SAR – Media OutReach Neswire – 24 March 2025 – SPACES II: Capturing the Ephemera, presented by HOFA Gallery and PhillipsX, explores new artistic and technological frontiers, expanding on the themes introduced in the inaugural SPACES exhibition in London during Frieze Week 2024. This latest instalment, taking place during Hong Kong Art Week 2025, reflects further on the intersection of art, technology and impermanence.
Featuring works by seven visionary artists; Refik Anadol, Sougwen Chung, Random International, Tyler Hobbs, Addie Wagenknecht, Gina Choy and Maja Petrić, the selling exhibition examines how technology can capture, preserve and transform fleeting moments into enduring artistic expressions. It runs from 28 March to 15 April 2025 at Phillips’ Asia headquarters in Hong Kong’s West Kowloon Cultural District.

SPACES is an innovative series of exhibitions that confronts the profound challenges and possibilities presented by computing technologies and their impact on human experience. The first edition, launched at Phillips London in 2024, explored the dynamic interplay between AI, generative art and digital creativity.
SPACES II examines how technology can give form to the impermanent, whether through environmental shifts, generative processes, or the fluidity of human perception and memory. The selling exhibition will showcases a diverse array of works, including immersive installations, generative digital art, algorithmic designs and contemporary mixed-media pieces.
Miety Heiden, Deputy Chairwoman and Head of Private Sales at Phillips, says: “Following the success of the first installment in London in 2024, we are thrilled to bring SPACES II: Capturing the Ephemera to Phillips Hong Kong in collaboration with HOFA Gallery. This exhibition continues our commitment to showcasing artists at the forefront of digital and generative art, exploring how technology transforms transient moments into lasting expressions. As part of Hong Kong Art Week 2025, we look forward to presenting these groundbreaking works to a global audience in our Asia headquarters.”
SPACES II: Capturing the Ephemera: Free and open to the public daily.
Dates: 27 March VIP & Press Preview. 28 March to 15 April 2025 (Closed on 4 April)
28-30 March 11:00-19:00
1-15 April 10:00-18:00
Venue: Phillips Asia Headquarters, 1F, WKCDA Tower, West Kowloon Cultural District, 8 Austin Road West, Kowloon
TheHouseofFineArt.com & Exhibitions.Phillips.com
Hashtag: #HOFAGallery #PhillipsX
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED5 years ago
Davos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz2 years ago
Estranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years ago
Sort Codes of GTBank Branches in Nigeria
-
Economy2 years ago
Subsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking2 years ago
First Bank Announces Planned Downtime
-
Sports2 years ago
Highest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn
-
Technology4 years ago
How To Link Your MTN, Airtel, Glo, 9mobile Lines to NIN